ASCO Update 2025

Im Fokus der Veranstaltung stehen praxisverändernde Studien und deren konkreter Einfluss auf die onkologische Versorgung in der Schweiz. Gemeinsam mit ausgewiesenen Expertinnen und Experten diskutieren wir die wichtigsten Erkenntnisse des ASCO-Kongresses und leiten daraus umsetzbare Empfehlungen für den klinischen Alltag ab. Ob Sie als Allgemeinonkologe tätig sind oder sich auf bestimmte Entitäten spezialisiert haben – diese Veranstaltung bietet Ihnen einen kompakten, aktuellen Überblick über relevante Entwicklungen und eine wertvolle Plattform für den kollegialen Austausch.

_{ASCO DIRECT™ programs are officially licensed by the American Society of Clinical Oncology, Inc. (ASCO). Each presentation is provided solely for educational and informational purposes and personal use only.  No part of any presentation may be edited or altered, or reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, nor may it be used for commercial purposes, without in each case the express written permission of ASCO.  The ideas and opinions expressed in this presentation do not necessarily reflect those of ASCO. The mention of any company, product, service, or therapy does not constitute an endorsement of any kind by ASCO.  It is the responsibility of the treating physician or other health care provider, relying on independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient. Viewers are advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each drug to be administered to verify , among other matters, the dosage, the method and duration of administration, or contraindications.  ASCO assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the material contained in this presentation or any errors or omissions.}

_{©2025 American Society of Clinical Oncology, Inc. All rights reserved worldwide.}